Position in BIIB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$36,916,612
-$2,128,529 QoQ
Shares Held
201,367
-9.2% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $179,007,948 across 10 Drug Manufacturers - General names. BIIB ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,004 | $61,628,269 | |
| 2 | JNJ |
Johnson & Johnson
|
164,590 | $40,232,379 | |
| 3 | BIIB |
Biogen Inc.
This page
|
201,367 | $36,916,612 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
100,010 | $13,938,393 | |
| 5 | MRK |
Merck & Co., Inc.
|
101,505 | $12,210,036 | |
| 6 | NVO |
Novo Nordisk A S
|
125,038 | $4,595,146 | |
| 7 | ABBV |
AbbVie Inc.
|
20,010 | $4,351,974 | |
| 8 | PFE |
Pfizer Inc
|
90,000 | $2,527,200 |
All Filings in BIIB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,916,612 | 201,367 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $39,045,141 | 221,860 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,461,392 | 253,151 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $33,625,466 | 267,740 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $27,439,156 | 200,520 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,854,943 | 241,008 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $58,152,000 | 300,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $45,204,900 | 195,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $48,516,750 | 225,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,933,950 | 135,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,203,325 | 82,500 | Shares | Sole | 2023-12-07 | |
| 2023-06-30 | $16,378,875 | 57,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,390,347 | 109,306 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $14,538,300 | 52,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,682,500 | 47,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,098,500 | 25,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,159,000 | 15,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,556,480 | 44,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,659,800 | 20,000 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $5,194,050 | 15,000 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $4,897,200 | 20,000 | Shares | Sole | 2021-03-04 | |
| 2020-09-30 | $14,184,000 | 50,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,708,625 | 47,500 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,163,800 | 10,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||